Background: Hispanic children with cancer experience poorer survival than their White counterparts. Infection is a known cause of cancer-related mortality; however, little is known about the risk of infection-related death among Hispanic children with cancer. We examine the association of Hispanic ethnicity with infection-related mortality and life-threatening events among children with cancer.
The cause of decreased survival rates among Hispanics remains unknown. Socioeconomic factors, including reduced access to care, have been implicated. [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] However, the effect of such factors in pediatric cancers is unclear. Likewise, both host and tumor biologic factors have been proposed as possible contributors to cancer survival disparities. However, definitive evidence linking any biologic differences to survival is lacking. [36] [37] [38] [39] Infections during cancer therapy may be an underappreciated potential contributor to disparities in survival among pediatric cancer patients. Whether or not a child survives a life-threatening infection may depend on the type of pathogen, the state of the immune system, baseline organ function, and the time to appropriate therapy. 40 Sepsis in severely immune-compromised patients is an important cause of cancer-related mortality. [41] [42] [43] Differences in sepsis mortality rates, based on ethnicity, have been demonstrated among adult patients with a variety of underlying conditions. [44] [45] [46] [47] [48] However, very little is known about the risk of life-threatening infection or sepsis among Hispanics and other minority children with cancer.
The current study describes the association of Hispanic ethnicity with infection-related mortality and life-threatening events requiring intensive care unit (ICU) admission in children with cancer. Using an institutional clinical database for a large tertiary children's hospital, linked with the Center for Disease Control and Prevention's (CDC) National Death Index (NDI), we evaluated the hazard ratio (HR) of infection-related mortality among Hispanic and Non-Hispanic pediatric cancer patients. We hypothesized that Hispanic children with cancer would be more likely to die from infections compared with NonHispanic patients. Then, to better understand an association between Hispanic ethnicity and infection-related mortality, we also explored whether Hispanic children were more likely to experience episodes of life-threatening sepsis or if differences in mortality could be explained by survivability of sepsis episodes. To that end, as most pediatric oncology patients with life-threatening conditions are admitted to the ICU, we evaluated rates of ICU admissions, as a surrogate for lifethreatening events, including sepsis, to identify episodes of severe illness that may or may not have resulted in death.
METHODS

Study cohort
Intermountain Healthcare (IH) is a healthcare system consisting of more than 185 clinics and 22 hospitals, including Primary Children's Hospital (PCH), a state-of-the-art hospital, located in Salt Lake City, UT, that serves as the pediatric tertiary care center for much of Utah, Idaho, Wyoming, Montana, and Nevada. IH maintains a cancer registry containing patient, diagnosis, and treatment data for all oncology patients who received at least some portion of their treatment within the IH system, to report to the Utah Surveillance, Epidemiology, and End Results Program registry. Patients in this registry, aged 0-25, who were diagnosed with a cancer designated in the International Classification of Childhood Cancers between January 1, 1986 and December 31, 2012, were included in the study cohort (N = 6,198; Fig. 1 ). 49 In 
Identification of deaths
For the full study cohort (n = 6,198), any patients that had a clinical visit in the IH system on, or after the last follow-up date, January 1, 2014, were presumed alive on January 1, 2014. This resulted in 4,135 individuals for which vital status was uncertain on January 1, 2014.
NDI records were queried for death records in the years during and after the most recent IH clinic visit for each of these patients. The NDI, which is operated by the CDC and maintains death certificate information for deaths occurring within the United States, has been utilized by hundreds of studies to identify deaths and causes of death, including infectious causes. [52] [53] [54] [55] [56] [57] [58] In accordance with NDI query standards, we sent eight individual identifiers per patient to increase the likelihood of exact matches and decrease the likelihood of false matches: first, middle, last name, month, day, and year of birth, gender, and state of birth. For patients with hyphenated last names, we sent three records that were identical except for the last name; the combined hyphenated name, and one for each of the hyphenated names alone, to ensure matching. Patients for whom no death record matched in the NDI query were presumed alive on January 1, 2014.
Each NDI record includes up to 20 listed causes of death as International Classification of Disease (ICD) codes. For purposes of analysis, deaths were defined both as "all-cause mortality" and as "infectionrelated mortality." Infection-related death was assigned based on a previously validated list of infection ICD 9 and 10 codes. 59, 60 
Demographic and clinical measures
Name, date of birth, and diagnosis were queried from the IH cancer registry. Rural versus urban residence at diagnosis was classified using Rural-Urban Commuting Area codes, a ZIP code-based geographic taxonomy system. 61, 62 Some patients had invalid or were missing ZIP codes.
Diagnosis type was separated into three categories: hematologic malignancies (leukemia or lymphoma), central nervous system (CNS) tumors, and non-CNS solid tumors.
Ethnicity
Ethnicity (Hispanic or non-Hispanic) was assigned using a previously described combined method 63 utilizing both a surname matching algorithm and ethnicity data from the Utah Population Database, a unique database providing clinical, demographic, and genealogic data on more than 7 million individuals in Utah dating back several generations.
Statistical methods
The main independent variable of interest was ethnicity. Chi-square tests were used to compare demographic variables by Hispanic or nonHispanic. for the Cox models were tested on the basis of Schoenfeld residuals.
Age at diagnosis was found to violate the assumption of proportionality in the Cox model for all-cause mortality. The model run with age at diagnosis stratified revealed similar HRs and CIs and, thus, we report the nonstratified model. Regression models were adjusted for gender, age at diagnosis, year of diagnosis, cancer diagnosis type (hematologic malignancy, CNS, or non-CNS solid tumor), and residential location.
For the subset of 3,179 patients diagnosed after 2001, for whom ICU admission data were available, Chi-square tests were used to compare demographic variables across the two ethnic groups. The rates of ICU admissions were modeled using zero-inflated Poisson (ZIP) regression models to account for the large number of patients with no admissions, using follow-up time as an offset. The ZIP regression model included ethnicity, gender, age at diagnosis, year of diagnosis, cancer diagnosis type, and residential location as covariates. All statistical analyses were performed using Stata, version 12. 64 All reported P values are two-sided and P less than 0.05 was considered statistically significant.
RESULTS
Demographic and clinical measures
After a mean follow-up of 10.97 years (SD = 8.04) for the full cohort, there were 1,205 deaths, with 193 of these attributable to infection. 
All-cause and infection-related mortality
In Table 2 , male patients, patients in earlier diagnosis years (1986-1990), and patients with CNS tumors were more likely to die from CI: = 1.04-2.39, P = 0.03) despite having a similar overall mortality.
TA B L E 2 Multivariable HRs and 95%
CIs for all-cause mortality and infection related mortality by ethnicity (N = 6,198)
ICU admissions
Among patients diagnosed after January 1, 2001, the pattern of demographic characteristics mirrored that of the overall sample with Hispanic patients being younger at diagnosis, more urban, diagnosed in more recent years, and more likely to have a hematologic malignancy. 
DISCUSSION
Our data demonstrate a higher risk of infection-related death among
Hispanics when compared with non-Hispanics in a cohort of pediatric oncology patients from a single institution. While all-cause mortality did not differ, remarkably Hispanic patients were 67% more likely to have an infection-related death than non-Hispanic patients.
In addition, we found rates of ICU admissions, which we examined as a surrogate measure of life-threatening events such as infections,
to be approximately one-third higher among Hispanic patients compared with non-Hispanic patients. To our knowledge, this is the first study specifically demonstrating these phenomena. Our findings that
Hispanic patients had higher rates of infection-related mortality and greater rates of ICU admissions point to a potentially underappreciated contributor to cancer mortality in this minority population. Hispanic families, compared with non-Hispanic Whites, are more likely to be socioeconomically vulnerable, have limited English proficiency, and encounter challenges to accessing quality health care. [30] [31] [32] While poor healthcare access has been associated with a delay in time to cancer diagnosis and more advanced cancer stage at diagnosis in a variety of adult cancers, [33] [34] [35] the effect of reduced healthcare access is less clear in pediatric cancer. 36 Timely delivery of antibiotics has been shown to vastly improve survival of septic children. 40, [65] [66] [67] [68] [69] [70] [71] [72] [73] It should be noted that Hispanic children were more likely to have a hematologic cancer, which was associated with infection-related mortality. However, our model adjusted for diagnosis to minimize possible confounding.
Another notable finding of our study was that patients diagnosed more recently were not only less likely to die from any cause but also less likely to die from an infection-related death. This is likely due to improvements in both prevention of treatment complications and supportive care for septic patients. 87 It is important to note that although Hispanic children were disproportionately diagnosed in more recent years in our sample, and thus, likely should have benefited from these improvements in infection prevention and supportive care, they were still more likely to experience an infection-related death.
Although patients diagnosed with CNS tumors were more likely to die due to any cause, compared with hematologic malignancies, they were less likely to have an infection-related death. The higher rate of all-cause mortality among CNS patients points to the worse prognosis for these patients due to the severity of the disease. 88 The lack of differences in all-cause mortality in our cohort, despite differences in the risk of infection-related deaths, may be due to certain study limitations. First, our study is from a single institution with a limited sample size. Several prior studies from single institutions and with small sample sizes also report no mortality disparities, 7, 9, 10, 96 where larger studies have demonstrated significant differences in mortality rates. 25 The proportion of Hispanic patients has risen dramatically over the last two decades, meaning that, on average, Hispanic patients were diagnosed and treated more recently. As treatment and overall survival rates have improved dramatically over time, 3,4 a higher proportion of Hispanics would have been treated with more contemporary therapy, which is associated with higher survival rates. However, a subanalysis of patients in our cohort diagnosed after 2001 revealed no significant differences in the overall mortality. Also, relying on an NDI query for death records may disproportionally impact the ability to capture death records for Hispanics given a higher rate of hyphenated surnames and potentially higher rates of emigration.
Indeed, national databases have traditionally overestimated overall mortality for non-Hispanic Whites while underestimating the overall mortality in minorities. 97 Of note, while we utilized a validated method of classifying patients as Hispanic versus non-Hispanic, making such distinctions has traditionally been difficult and may introduce error. While the NDI is a very powerful tool for evaluating mortality for those dying in the United States, it does not capture those who may have died outside the United States. Therefore, our query may underestimate the overall mortality for segments of patients who are more likely to emigrate. In addition, NDI queries rely on accurate and specific patient identifiers, which may not be equally reliable between our two main cohorts of interest. In addition, with the exception of our Hispanic cohort, given our regional demographics, we were unable to evaluate the risk of infection-related mortality in other ethnic minorities. Lastly, due to the relatively small number of ICU admissions, and diversity of diagnoses, we were unable to systematically evaluate diagnosis codes associated with those admissions. Future research should evaluate causes of admission across ethnicities.
In conclusion, we found that Hispanic children with cancer were more likely to experience an infection-related death and experienced a higher rate of ICU admissions in comparison with a cohort of nonHispanic pediatric oncology patients. While we were unable to demonstrate a difference in the overall mortality between the two groups in this single-institution study, these data introduce infectious complica- 
